| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Blue Coat (BLCT) | Morgan Stanley/ J.P. Morgan/ Credit Suisse/ Goldman, Sachs | $100.00 | n.a. | |||
| IMPINJ (PI) | RBC Capital Markets/ Pacific Crest Securities (a division of KeyBanc Capital Markets)/ Piper Jaffray | $60.00 | n.a. | |||
| JELD-WEN Holding (TBA) | Barclays/ Citigroup/ Credit Suisse/ J.P. Morgan | $100.00 | n.a. | |||
| Syros Pharmaceuticals (SYRS) | Cowen and Company/ Piper Jaffray | $69.00 | n.a. | |||
| Valvoline (VVV) | BofA Merrill Lynch/ Citigroup/ Morgan Stanley | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| At Home Group (HOME) | BofA Merrill Lynch/ Goldman Sachs/ Jefferies/ Morgan Stanley | $100.00 | n.a. | |||
| Atkore International Group (ATKR) | Credit Suisse/ Deutsche Bank Securities/ J.P. Morgan/ UBS Investment Bank | 12.00 | $20.00 | $22.00 | $252.00 | 2-Stars |
| Elevate Credit (ELVT) | UBS Securities/ Jefferies/ Stifel/ William Blair & Company | 3.60 | $20.00 | $22.00 | $75.60 | 1-Star |
| n.a. (not available) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of May 30, 2016 | Manager(s) | Offered | Raised | Price | 6/3/16 | Change |
| Nant Health (NH) | Jefferies/ Cowen and Company | 6.50 | $91.00 | $14.00 | $18.54 | 32.43% |
| Sensus Healthcare (SRTSU) (u) | Northland Capital Markets/ Neidiger Tucker Bruner | 2.00 | $11.00 | $5.50 | $6.45 | 17.27% |
| Clearside Biomedical (CLSD) | Cowen and Company/ Stifel | 7.20 | $50.40 | $7.00 | $7.06 | 0.86% |
| u (unit offering) | ||||||
